NAF works with the most knowledgeable, accomplished Ataxia researchers in the world. We are committed to providing the resources needed to pursue a cure and better quality of life for people with Ataxia.
For new and innovative studies that are relevant to the cause, pathogenesis or treatment of the hereditary or sporadic ataxias. Offered primarily as “seed monies” to assist investigators in the early or pilot phase of their studies and as additional support for ongoing investigations on demonstration of need.
The Pioneer SCA3/MJD Translational Research Award is for a research project that will facilitate the development of treatments for Spinocerebellar Ataxia Type 3/Machado Joseph Disease.
Post-doctoral fellowship awards are to serve as a bridge from post-doctoral positions to junior faculty positions. Applicants should have shown a commitment to research in the field of Ataxia.
The Young Investigator Award was created to encourage young clinical and scientific investigators to pursue a career in the field of Ataxia research. It is our hope that Ataxia research will be invigorated by the work of young, talented individuals supported by this award.
This URM Pre-doctoral research fellowship is a competitive, non-renewable, merit-based award intended to enhance research and/or clinical training of promising students who are matriculated in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists aimed at continuing ataxia basic science, translational science or clinical research towards the goal of serving individuals with ataxia.
This award provides partial support for study and research and may be used to support pre-doctoral students who are pursuing research with an ataxia-relevant theme. Proposals across the spectrum of basic, translational, and clinical research are welcome.
The 2021 application cycle has closed. Please check back in January 2022 for instructions regarding the 2022 funding cycle.
NAF utilizes proposalCENTRAL for grant applications.
1. If a letter of support is required for a grant, can I provide two letters of support?
Yes, if you would like to provide additional letters of support, please upload to proposalCENTRAL during the application process. However, only one letter of recommendation is required.
2. I have previously been granted a Young Investigator Award, may I apply for another Young Investigator Award in this new funding cycle?
No, please check your eligibility for NAF’s other grant types and consider applying for a different NAF grant.
3. When applying for a Young Investigator Award, is there a time restriction for amount of years after obtaining my PhD in order to be eligible?
There is no time restriction regarding amount of years after obtaining a PhD. However, applicants must not be an Associate Professor or higher.
4. I am currently a student working towards my PhD, is there a grant available for me?
The Diverse Scientists in Ataxia Pre-doctoral Research Fellowship is available for those who meet the qualifications.
NAF hosts an annual patient conference each year which is attended by those affected by Ataxia and their caregivers/family members. Attendance is often over 500 individuals. Presentations by leading Ataxia researchers are given during the 2-day conference. Ataxia researchers are invited to participate in the exhibit area of the meeting to recruit patients for IRB approved research studies or share their research findings.
If you are interested in recruiting patients at NAF’s Annual Ataxia Conference, please contact us at (763) 553-0020 or email firstname.lastname@example.org.
The Centralized Ataxia Genomics Core (CAGC) is a freely accessible resource developed with support from the National Ataxia Foundation and hosted within the Clinical Neurogenomics Research Center based at the University of California, Los Angeles. This application is designed to facilitate connections within the ataxia research community related to shared interest in the same gene(s) and/or genetic variant(s). The goal of the CAGC is to improve collaboration to help solve undiagnosed ataxia cases through a centralized ataxia-specific data repository of genomic data collected from both research and/or clinical sources.